Preview

Product Team Cialis Getting Ready to Market

Satisfactory Essays
Open Document
Open Document
771 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Product Team Cialis Getting Ready to Market
Differentiation & Positioning
Case: Product Team Cialis_Getting Ready to Market (HBS 9-505-038)

The Actors: - Mark Babato, the executive director and global product team leader for Cialis - Rob Brown, the global marketing director from Lilly - Leonard Blum, vice president of sales and marketing from ICOS - Sidney Taurel, Chairman of the Board, President and CEO of Lilly

Problem Analysis:

| |VIAGRA |CIALIS |
|The effect |approx. 4 hours after dosing |36 hours after taking the drugs |
|The absorption |Diminished when the drug was taken during or |Not affected by food intake |
| |after a high-fat meal | |
|Conjunction with Nitrates |Forbidden |Forbidden |
|Visual irregularities |Yes |Rare |

- The Lilly ICOS LLC joint venture was signed on September 30, 1998. - Profits from future sales of drugs in North America and Europe would be split 50/50 - Profits from sales of drugs in other regions were to be retained by Lilly, after a royalty was paid to the joint venture

Marketing Competence at Lilly:

Lilly should re-thought the way of marketing by integrate into product development and introduction due to several reasons: a. Many of the pharmaceutical companies were embracing a high-risk high-return strategy b. Industry resources were increasingly being allocated to the development of “quality-of-life” medicines c. The FDA revised the rules on prescription drug promotion in 1997. This facilitated direct-to-consumer

You May Also Find These Documents Helpful

  • Good Essays

    1.Problem StatementLilly- ICOS LLC is about to launch a new and innovative product intended to help men suffering from Erectile Dysfunction (ED). Because of the unique product features, Cialis - the product - has good chances of becoming successful even though it is entering a segment, where Pfizer's Viagra is the undisputed market leader. In this context, Lilly- ICOS LLC must decide on a marketing strategy, in particular which groups to target and which positioning thus which communication strategy to choose.…

    • 1451 Words
    • 5 Pages
    Good Essays
  • Better Essays

    Mktg 205 Unit 4 Ip

    • 2787 Words
    • 12 Pages

    When marketing any kind of product, the producer should take in to consideration the elements that will impact their business. If they can come up with solutions to these problems then they products are more than likely to succeed.…

    • 2787 Words
    • 12 Pages
    Better Essays
  • Satisfactory Essays

    Trueblood Case 09 2

    • 804 Words
    • 2 Pages

    The agreement states Pharmagen will receive up to $500 million funding for R&D costs as they are incurred solely for the research efforts of a potential new drug “X”…

    • 804 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Hcs/ 490 Outline

    • 475 Words
    • 2 Pages

    d. Ensure that customers and medical specialists are given enough info about prescription drugs on branding and marketing IV. The chosen medical goods or services classification a. Drug Advertising, Branding and Publicity V. Reason for selecting this section a. The DDMAC division of the FDA is accountable for regulating conformity in advertising, branding and public relations. b. The DDMAC is accountable for proficient healthcare promotional procedures for direct-to-consumers advertising c. Info is given as well as what may or may not be included in end-user copies. VI. Conclusion a. Associate the significance of FDA regulations on drugs with existing measures…

    • 475 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    An issue with the distribution of drugs is that it is more profitable for drug companies to sell the drugs in MEDC’s than LEDC’s. An example of this would be GlaxoSmithKline, as they mainly sell their products in MEDC’s, but in many cases, the countries with…

    • 381 Words
    • 2 Pages
    Good Essays
  • Powerful Essays

    Pharmacology Review Sheet

    • 11954 Words
    • 48 Pages

    After a drug is administered, it must get to the site where it exerts its action. This phase of pharmacokinetics is called…

    • 11954 Words
    • 48 Pages
    Powerful Essays
  • Good Essays

    Pharmagen entered into a funding agreement with Company XYZ, an unrelated third-party private equity investor (PEI)…

    • 960 Words
    • 4 Pages
    Good Essays
  • Satisfactory Essays

    Q5 this business model is very risky, the key is to have expertise in identifying the drugs, which were abandoned by the parent companies for any reason. Pharmaceutical companies, after spending millions of dollars in research, don’t typically abandon their product development, unless they are convinced that their product would be a failure, due to variety of reasons. If proper identification can be done, it saves a large chunk of R&D dollars, especially if the drug is in later stages of development.…

    • 533 Words
    • 3 Pages
    Satisfactory Essays
  • Good Essays

    Drug Dilemmas

    • 521 Words
    • 3 Pages

    3. Finally, do drug companies have an obligation to make new drugs available to patients who were involved in their development in the U.S. or overseas?…

    • 521 Words
    • 3 Pages
    Good Essays
  • Better Essays

    Merck & Co

    • 1066 Words
    • 5 Pages

    1. How has Merck been able to achieve substantial returns to capital given the large costs and lengthy time to develop a new drug?…

    • 1066 Words
    • 5 Pages
    Better Essays
  • Good Essays

    Genzyme Case Study

    • 745 Words
    • 3 Pages

    1. How does Genzyme’s focus on orphan drugs affect the degree of competition it faces? How does it affect the bargaining power of customers?…

    • 745 Words
    • 3 Pages
    Good Essays
  • Good Essays

    * Pfizer: Pharmaceutical companies have low pressures for local responsiveness as their products serve universalistic needs. Cost pressures on the other hand are intense therefore the most appropriate strategy is a Global one.…

    • 670 Words
    • 3 Pages
    Good Essays
  • Good Essays

    A very large pharmaceutical company with headquarters in Indianapolis, Eli Lilly has a proactive attitude toward new technologies. It began exploring the potential of the Internet in 1993. Managers soon realized that, by using intranets, they could reduce many of the problems associated with developing applications on a wide variety of hardware platforms and networking configurations. Because the benefits were so obvious, the regular financial justification process was waived for intranet application development projects. The IS group that helps user departments develop and maintain intranet applications increased its staff from three to ten employees in 15 months.…

    • 728 Words
    • 3 Pages
    Good Essays
  • Satisfactory Essays

    Law421/ week 5 final team

    • 546 Words
    • 2 Pages

    Genture developed a new drug for diabetes and is looking to partnership with CadMex to manufacture and market the drug at an international level. This week’s provides a brief overview of international legal and ethical issues in international transactions.…

    • 546 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    Appex Business Case

    • 885 Words
    • 3 Pages

    In mid-89 the company added product teams, allowing the organization to improve its planning capabilities through differentiation of key products lacking however to prioritize its most relevant portfolio’s products and demonstrate strong authority. As a matter of fact, the consequent…

    • 885 Words
    • 3 Pages
    Good Essays